We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Vicor
VICR
$9.77B
| $10.5M | 0.02% |
193,613
+440
| +0.2% | +$27.3K |
|
652
Assured Guaranty
AGO
$3.35B
| $10.4M | 0.02% |
189,255
+103,374
| +120% | +$5.97M |
|
653
DT Midstream
DTM
$13.9B
| $10.4M | 0.02% |
215,368
+33,868
| +19% | +$1.85M |
|
654
American Eagle Outfitters
AEO
$2.94B
| $10.4M | 0.02% |
931,041
+309,886
| +50% | +$4.37M |
|
655
Flowserve
FLS
$10.2B
| $10.4M | 0.02% |
366,999
-457,779
| -56% | -$14.6M |
|
|
SWI
656
DELISTED
SolarWinds Corporation Common Stock
SWI
| $10.3M | 0.02% |
1,003,666
+229,040
| +30% | +$2.72M |
|
|
JWN
657
DELISTED
Nordstrom
JWN
| $10.3M | 0.02% |
486,158
+143,904
| +42% | +$3.68M |
|
|
JNPR
658
DELISTED
Juniper Networks
JNPR
| $10.2M | 0.02% |
360,934
+89,444
| +33% | +$2.82M |
|
659
Encompass Health
EHC
$12.5B
| $10.1M | 0.02% |
227,733
+17,153
| +8% | +$880K |
|
660
DoorDash
DASH
$92.7B
| $10.1M | 0.02% |
162,147
+94,771
| +141% | +$7.53M |
|
661
Churchill Downs
CHDN
$6.18B
| $10.1M | 0.02% |
107,930
+74,378
| +222% | +$7.4M |
|
662
Lumentum
LITE
$62.9B
| $10M | 0.02% |
126,526
-68,614
| -35% | -$5.86M |
|
663
Aecom
ACM
$8.74B
| $9.98M | 0.02% |
157,576
+18,344
| +13% | +$1.28M |
|
664
Healthcare Realty
HR
$6.58B
| $9.93M | 0.02% |
355,609
+15,523
| +5% | +$461K |
|
665
Perrigo
PRGO
$1.75B
| $9.91M | 0.02% |
244,404
+135,333
| +124% | +$5.03M |
|
|
DFS
666
DELISTED
Discover Financial Services
DFS
| $9.9M | 0.02% |
107,552
+48,407
| +82% | +$5.18M |
|
667
Federated Hermes
FHI
$4.74B
| $9.81M | 0.02% |
314,067
-67,847
| -18% | -$2.15M |
|
668
Idexx Laboratories
IDXX
$46.6B
| $9.7M | 0.02% |
27,897
-18,109
| -39% | -$7.38M |
|
669
Realty Income
O
$58.6B
| $9.69M | 0.02% |
142,030
-22,861
| -14% | -$1.57M |
|
670
Littelfuse
LFUS
$11.7B
| $9.69M | 0.02% |
38,304
+5,796
| +18% | +$1.45M |
|
671
SL Green Realty
SLG
$3.94B
| $9.66M | 0.02% |
211,309
+150,155
| +246% | +$9.55M |
|
672
American Financial Group
AFG
$12B
| $9.65M | 0.02% |
71,504
+1,913
| +3% | +$269K |
|
673
Aflac
AFL
$61.1B
| $9.64M | 0.02% |
176,257
+60,854
| +53% | +$3.59M |
|
674
Walt Disney
DIS
$179B
| $9.63M | 0.02% |
103,615
+5,170
| +5% | +$574K |
|
|
MPT
675
Medical Properties Trust
MPT
$2.5B
| $9.59M | 0.02% |
628,299
+573,101
| +1,038% | +$10.3M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.